Surrozen Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
44
- Stock Symbol
-
SRZN
- Investments
-
1
- Share Price
-
$31.61
- (As of Friday Closing)
Surrozen General Information
Description
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
Contact Information
Website
www.surrozen.comCorporate Office
- 171 Oyster Point Boulevard
- Suite 400
- South San Francisco, CA 94080
- United States
Corporate Office
- 171 Oyster Point Boulevard
- Suite 400
- South San Francisco, CA 94080
- United States
Surrozen Timeline
Surrozen Stock Performance
As of 13-Nov-2026, Surrozen’s stock price is $31.61. Its current market cap is $603M with 19.1M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $31.61 | $31.78 | $12.31 - $37.83 | $603M | 19.1M | 527K | -$41.94 |
Surrozen Financials Summary
As of 30-Sep-2026, Surrozen has a trailing 12-month revenue of $10.5M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 282,506 | 119,461 | 17,150 | (20,313) |
| Revenue | 10,528 | 3,477 | 10,655 | 0 |
| EBITDA | (393,549) | (244,509) | (63,815) | (43,471) |
| Net Income | (390,211) | (242,026) | (63,564) | (43,042) |
| Total Assets | 109,035 | 98,726 | 48,467 | 46,080 |
| Total Debt | 5,837 | 6,639 | 8,469 | 3,379 |
Surrozen Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Surrozen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Surrozen Comparisons
Industry
Financing
Details
Surrozen Competitors (31)
One of Surrozen’s 31 competitors is Gamida Cell, a Formerly VC-backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Gamida Cell | Formerly VC-backed | Boston, MA | ||||
| Capricor Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Lisata Therapeutics | Corporation | Basking Ridge, NJ | ||||
| Mesoblast | Corporation | Melbourne, Australia | ||||
| Regenerative Medical Solutions | Venture Capital-Backed | Madison, WI |
Surrozen Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Surrozen Patents
Surrozen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021173726-A1 | Wnt super agonists | Inactive | 24-Feb-2020 | ||
| WO-2021003416-A1 | Monospecific anti-frizzled antibodies and methods of use | Inactive | 02-Jul-2019 | ||
| WO-2020206005-A1 | Modulation of wnt signaling in auditory disorders | Inactive | 02-Apr-2019 | ||
| WO-2020185960-A1 | Modulation of wnt signaling in gastrointestinal disorders | Inactive | 11-Mar-2019 | ||
| WO-2020167848-A1 | Modulation of wnt signalling in ocular disorders | Inactive | 11-Feb-2019 | C07K16/22 |
Surrozen Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Surrozen Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Surrozen Acquisitions (1)
Surrozen’s most recent deal was a Merger/Acquisition with Consonance-HFW Acquisition. The deal was made on 11-Aug-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Consonance-HFW Acquisition | 11-Aug-2021 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Surrozen ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Surrozen FAQs
-
When was Surrozen founded?
Surrozen was founded in 2015.
-
Where is Surrozen headquartered?
Surrozen is headquartered in South San Francisco, CA.
-
What is the size of Surrozen?
Surrozen has 44 total employees.
-
What industry is Surrozen in?
Surrozen’s primary industry is Drug Discovery.
-
Is Surrozen a private or public company?
Surrozen is a Public company.
-
What is Surrozen’s stock symbol?
The ticker symbol for Surrozen is SRZN.
-
What is the current stock price of Surrozen?
As of 13-Nov-2026 the stock price of Surrozen is $31.61.
-
What is the current market cap of Surrozen?
The current market capitalization of Surrozen is $603M.
-
What is Surrozen’s current revenue?
The trailing twelve month revenue for Surrozen is $10.5M.
-
Who are Surrozen’s competitors?
Gamida Cell, Capricor Therapeutics, Lisata Therapeutics, Mesoblast, and Regenerative Medical Solutions are some of the 31 competitors of Surrozen.
-
What is Surrozen’s annual earnings per share (EPS)?
Surrozen’s EPS for 12 months was -$41.94.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
